Clinical Trial Update: The Effects of Glucagon on Hepatic Metabolism in People With Type 2 Diabetes After Caloric Restriction [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating how glucagon affects hepatic metabolism in adults with Type 2 diabetes after caloric restriction; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• GLUCAGON (GLUCAGON)

Snippet

Sponsor: Adrian Vella | Conditions: Type2diabetes | Phase 2 | Status: RECRUITING